Intelgenx Technologs
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral fil… Read more
Market Cap & Net Worth: Intelgenx Technologs (IGXT)
Intelgenx Technologs (PINK:IGXT) has a market capitalization of $29.69 Million ($29.69 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #24849 globally and #8530 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intelgenx Technologs's stock price $0.17 by its total outstanding shares 174658000 (174.66 Million).
Intelgenx Technologs Market Cap History: 2015 to 2025
Intelgenx Technologs's market capitalization history from 2015 to 2025. Data shows change from $90.80 Million to $29.69 Million (-11.41% CAGR).
Intelgenx Technologs Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intelgenx Technologs's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
23.53x
Intelgenx Technologs's market cap is 23.53 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $90.80 Million | $5.09 Million | $1.29 Million | 17.82x | 70.34x |
| 2016 | $136.23 Million | $5.22 Million | -$1.18 Million | 26.10x | N/A |
| 2017 | $137.98 Million | $5.20 Million | -$3.05 Million | 26.56x | N/A |
| 2018 | $94.32 Million | $1.82 Million | -$10.11 Million | 51.71x | N/A |
| 2019 | $82.09 Million | $742.00K | -$11.87 Million | 110.63x | N/A |
| 2020 | $38.42 Million | $1.54 Million | -$8.25 Million | 24.89x | N/A |
| 2021 | $62.88 Million | $1.53 Million | -$9.31 Million | 40.96x | N/A |
| 2022 | $34.93 Million | $950.00K | -$11.97 Million | 36.77x | N/A |
| 2023 | $24.45 Million | $1.04 Million | -$9.93 Million | 23.53x | N/A |
Competitor Companies of IGXT by Market Capitalization
Companies near Intelgenx Technologs in the global market cap rankings as of March 19, 2026.
Key companies related to Intelgenx Technologs by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Intelgenx Technologs Historical Marketcap From 2015 to 2025
Between 2015 and today, Intelgenx Technologs's market cap moved from $90.80 Million to $ 29.69 Million, with a yearly change of -11.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $29.69 Million | 0.00% |
| 2024 | $29.69 Million | +21.43% |
| 2023 | $24.45 Million | -30.00% |
| 2022 | $34.93 Million | -44.44% |
| 2021 | $62.88 Million | +63.64% |
| 2020 | $38.42 Million | -53.19% |
| 2019 | $82.09 Million | -12.96% |
| 2018 | $94.32 Million | -31.65% |
| 2017 | $137.98 Million | +1.28% |
| 2016 | $136.23 Million | +50.03% |
| 2015 | $90.80 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Intelgenx Technologs was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.69 Million USD |
| MoneyControl | $29.69 Million USD |
| MarketWatch | $29.69 Million USD |
| marketcap.company | $29.69 Million USD |
| Reuters | $29.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.